Pathogenic microorganisms via environmental modification

Pathogenic microorganisms via environmental modification is a pharmacological classification rather than a specific molecular target such as a receptor or enzyme (StatPearls, 2023). It describes a therapeutic approach where drugs exert their effects by altering the physical or chemical environment—most commonly the pH—of a specific body compartment to inhibit the growth or survival of pathogens (Merck Manual, 2022). For instance, urinary acidifiers like ammonium chloride create an acidic environment that is bacteriostatic, while methenamine acts as a prodrug that releases formaldehyde only in acidic conditions to kill bacteria (StatPearls, 2023). Because this target encompasses a wide range of non-specific actions and does not involve a discrete protein or gene, it is considered a functional or environmental category in drug discovery rather than a molecular entity (IUPHAR/BPS). This approach is primarily utilized for localized treatments where the goal is to neutralize pathogens or their environment without the need for high-affinity molecular binding.

Other names

Non-specific antimicrobial actionEnvironmental pH modulationPhysicochemical environmental modificationNon-protein target: Pathogenic microorganisms

Modification of the chemical or physical environment (e.g., pH, osmolarity) to inhibit the survival, growth, or virulence of pathogenic microorganisms or to facilitate the conversion of a prodrug into an active antimicrobial agent (Merck Manual, 2022; StatPearls, 2023).